SYNCOPE
Clinical trials for SYNCOPE explained in plain language.
Never miss a new study
Get alerted when new SYNCOPE trials appear
Sign up with your email to follow new studies for SYNCOPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Next-Day clinic aims to cut hospital admissions for common ailments
Disease control CompletedThis study tested a new clinic that sees emergency room patients the next day for conditions like pneumonia, heart failure, and kidney injury. The goal was to avoid hospital stays and improve patient care. About 570 adults took part, and researchers measured how many days they we…
Matched conditions: SYNCOPE
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Week-Long heart patch could Out-Sleuth standard 24-Hour monitor for palpitations
Diagnosis CompletedThis study tests whether a 7-day adhesive ECG patch (MEMO Patch) can detect more heart rhythm abnormalities than a conventional 24-hour Holter monitor in adults who experience palpitations or dizziness. Participants wear both devices at the same time for the first day, then conti…
Matched conditions: SYNCOPE
Phase: NA • Sponsor: HUINNO Co., Ltd • Aim: Diagnosis
Last updated Aug 01, 2026 00:00 UTC
-
Could a bladder drug help POTS patients stop fainting?
Symptom relief CompletedThis small pilot study tested whether mirabegron, a drug typically used for overactive bladder, can raise blood pressure and reduce fainting in people with POTS who have low blood pressure that standard treatments didn't help. Twenty adults took either 25 mg or 50 mg of the drug …
Matched conditions: SYNCOPE
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Can kids wear a heart patch for 14 days? study says yes!
Knowledge-focused CompletedThis study tested whether a small, band-aid-like heart monitor (Zio patch) can be worn by children for up to 14 days. It involved 36 kids aged 1 to 17 years. The goal was to see if the patch sticks well and gives clear heart signals. The study did not test any treatment, only the…
Matched conditions: SYNCOPE
Phase: NA • Sponsor: iRhythm Technologies, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC